Tudor Investment Corp’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.03M | Sell |
72,687
-74,404
| -51% | -$6.17M | 0.01% | 518 |
|
2025
Q1 | $11.9M | Buy |
147,091
+72,307
| +97% | +$5.86M | 0.04% | 228 |
|
2024
Q4 | $6.74M | Buy |
74,784
+19,307
| +35% | +$1.74M | 0.03% | 345 |
|
2024
Q3 | $5.48M | Buy |
55,477
+38,122
| +220% | +$3.77M | 0.02% | 426 |
|
2024
Q2 | $1.61M | Sell |
17,355
-94,527
| -84% | -$8.76M | 0.01% | 807 |
|
2024
Q1 | $10.6M | Buy |
111,882
+98,054
| +709% | +$9.3M | 0.07% | 216 |
|
2023
Q4 | $1.23M | Sell |
13,828
-7,028
| -34% | -$628K | 0.01% | 871 |
|
2023
Q3 | $1.52M | Buy |
20,856
+3,427
| +20% | +$250K | 0.02% | 754 |
|
2023
Q2 | $1.45M | Buy |
+17,429
| New | +$1.45M | 0.02% | 764 |
|
2017
Q1 | – | Sell |
-325,000
| Closed | -$19.2M | – | 1565 |
|
2016
Q4 | $19.2M | Buy |
+325,000
| New | +$19.2M | 0.5% | 25 |
|